NATHBIOGEN152.50

Nath Bio-Genes (India) Limited

· FMCG & Retail
AnnualQuarterly₹ CrorePeersSARVESHWARINDOUSSUKHJITSKOHINOORAGRITECHREGAALBSHSLGULPOLYMcap ₹290 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations332.6364.9445.1489.8
Other Income0.64.57.87.9
Total Income333.3369.5452.9497.8
Expenses
+ Cost of Materials Consumed142.5225.5306.2311.8
+ Purchases of Stock-in-Trade12.312.77.74.6
+ Changes in Inventories-21.2-102.7-112.4-89.9
+ Employee Benefit Expense28.332.535.837.0
+ Finance Costs9.110.516.017.1
+ Depreciation & Amortisation3.33.84.04.0
+ Other Expenses120.9147.1155.4177.0
Total Expenses295.1329.4412.6461.6
EBITDA49.949.852.449.3
EBIT46.646.048.545.3
Profit
PBT before Exceptional Items38.140.040.336.2
+ Exceptional Items3.40.56.07.2
Pretax Income41.640.646.343.4
+ Current Tax1.92.04.54.6
+ Deferred Tax0.0-0.10.20.2
Tax Expense1.92.04.74.7
+ Share of Associates & JVs0.00.00.0-2.1
Net Income39.638.641.636.6
+ Net Income — Continuing Ops39.638.641.638.7
+ Other Comprehensive Income0.9-0.3-1.8-1.5
Total Comprehensive Income40.538.339.935.1
Per Share
Basic EPS21.3420.1420.9818.43
Diluted EPS21.3420.1420.9818.43
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.3-1.8-1.5
+ Tax on Items NOT to be Reclassified0.11.91.7
+ Tax on Items NOT to be Reclassified — alt tag0.1
+ Tax on Items to be Reclassified0.3-0.1-0.2
+ Tax on Items to be Reclassified — alt tag-1.0
Per Share — as-filed variants
Basic EPS — Continuing Operations21.340.0020.9818.43
Diluted EPS — Continuing Operations21.340.0020.9818.43
Basic EPS — Discontinued Operations0.0020.140.000.00
Diluted EPS — Discontinued Operations0.0020.140.000.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit199.1229.4243.6263.3
Gross Margin %59.8462.8554.7353.76
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)38.140.040.336.2
− Exceptional Items (reconciliation)3.40.56.07.2
Net Income Adj (tax-effected)36.338.136.230.2
EPS Adj19.5719.8718.2615.20
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital19.019.019.019.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.